← Open Payments lookup

JAY HOEKSEMA: Open Payments

NPI 1124625926 · PERU, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$328 in 16 payments from 12 companies in 2025. Trend: 2023 $84 · 2024 $610 · 2025 $328

Food & beverage: $328
CompanyPaymentsAmount
ABBVIE INC.4$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Alkermes, Inc.1$33
Novo Nordisk Inc1$32
E.R. Squibb & Sons, L.L.C.1$27
Gilead Sciences, Inc.1$23
GlaxoSmithKline, LLC.1$23
AstraZeneca Pharmaceuticals LP1$19
Indivior Inc.1$18
Lundbeck LLC1$16

Products named: CAPLYTA, QULIPTA, VIVITROL, Ozempic, COBENFY, BEXSERO, SUBLOCADE, REXULTI.

Industry payments across IN — which companies pay providers there.